CYTK

Cytokinetics, Incorporated News Headlines

$7.38
*  
0.33
4.68%
Get CYTK Alerts
*Delayed - data as of Jan. 23, 2015  -  Find a broker to begin trading CYTK now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CYTK Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Cytokinetics Growth-By-Partnership Strategy Looks Viable When It Comes To CK-2127107
4/2/2013 3:27:00 AM - Seeking Alpha


ANTH's Blisibimod Enters Phase III - Analyst Blog
4/1/2013 6:11:38 PM - Zacks.com


Gilead's HCV Study to Continue - Analyst Blog
4/1/2013 4:05:01 PM - Zacks.com


Bad News for Alexion, Shares Down - Analyst Blog
4/1/2013 3:07:41 PM - Zacks.com


Omeros Progresses with OMS824 - Analyst Blog
3/28/2013 6:26:44 PM - Zacks.com


Takeda Seeks Japanese Approval - Analyst Blog
3/28/2013 5:31:05 PM - Zacks.com


Balanced View on Gilead Sciences - Analyst Blog
3/28/2013 5:26:33 PM - Zacks.com


Setback for Idenix Pharma - Analyst Blog
3/28/2013 5:24:42 PM - Zacks.com


LabCorp Remains at Neutral - Analyst Blog
3/28/2013 3:31:17 PM - Zacks.com


LIFE Explores China's Growth Potential - Analyst Blog
3/28/2013 2:28:46 PM - Zacks.com


Affymetrix Inks Deal with UK Biobank - Analyst Blog
3/28/2013 1:29:24 PM - Zacks.com


Takeda Files Adcetris in Japan - Analyst Blog
3/27/2013 2:26:29 PM - Zacks.com


Acorda Reports Data on Epilepsy Drug - Analyst Blog
3/26/2013 3:27:57 PM - Zacks.com


Integra's Second Cobalt Chrome Rod - Analyst Blog
3/26/2013 3:25:44 PM - Zacks.com


Zimmer Optimistic About New Product - Analyst Blog
3/26/2013 3:17:01 PM - Zacks.com


CHMP Negative on Gentium Candidate - Analyst Blog
3/26/2013 9:28:43 AM - Zacks.com


CHMP Positive on Ariad's Iclusig - Analyst Blog
3/25/2013 5:27:49 PM - Zacks.com


CHMP Still Negative on Isis' Kynamro - Analyst Blog
3/25/2013 4:32:02 PM - Zacks.com


Pipeline Setback at BioLineRx - Analyst Blog
3/25/2013 3:29:40 PM - Zacks.com


CHMP Positive on Biogen's Tecfidera - Analyst Blog
3/25/2013 9:29:17 AM - Zacks.com


Cytokinetics: Critical Phase IIb Data Is Upcoming In 2013 For Omecamtiv Mecarbil And Tirasemtiv
3/25/2013 8:56:11 AM - SeekingAlpha


FDA Nod for Integra's Extremity Offer - Analyst Blog
3/22/2013 5:29:06 PM - Zacks.com


NICE News for InterMune - Analyst Blog
3/22/2013 5:26:11 PM - Zacks.com


PetMed Reiterated at Outperform - Analyst Blog
3/22/2013 4:27:20 PM - Zacks.com


Zimmer Expands Knee Product Offering - Analyst Blog
3/22/2013 3:25:40 PM - Zacks.com